AnteoTech Builds on Success with Molecular Diagnostics for Covid-19
Fresh from success battling Covid-19, Australian biotech company AnteoTech is setting up for rapid expansion based upon its AnteoBind technology for improved molecular conjugation. Armed with $12 million in new funding, the company is developing more tests and its […]